GL1X · GenesisL1 explorer

MolNFT v1 · #136930 · protein

The crystal structure of the protein of degv family COG1307 from ruminococcus gnavus atcc 29149 (alternative refinement of pdb 3JR7 with vaccenic acid)

5V85 · Edd domain protein, degv family: “The crystal structure of the protein of degv family COG1307 from ruminococcus gnavus atcc 29149 (alternative…”. X-ray diffraction, 3 ligands (VCA, NA, PO4), 10 pockets (best druggability 0.80).…

PDB
5V85
Type
protein
Length
557 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Edd domain protein, degv family
UniProt
A7B6P0
Ligands
VCA, NA, PO4
Pockets
10 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEdd domain protein, degv familyprotein27840% helix, 24% strandA7B6P0
BEdd domain protein, degv familyprotein27939% helix, 24% strandA7B6P0

Ligands and binding sites

  • VCA · Vaccenic acid · ligand · 2 copies · chains A, B
  • NA · Sodium ion · metal · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11570.800.9629VCA
21580.790.9529VCA
33510.590.7633empty
41610.520.7923empty
51820.470.7628empty

Interfaces

1 interface between chains.

  • A–B · 602 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 14 modified, 1 disulfide (engineered, disulfide).

Compared structures

  • 5V85 · The crystal structure of the protein of DegV family COG1307 from Ruminococcus gnavus ATCC… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.